LumaCyte has earned the CE Mark for its Radiance device, a single-cell analysis instrument used to organize and characterize individual cells.

The system allows researchers to characterize and sort individual cells by measuring their optical and fluidic forces using laser technology.

The platform has potential for use in vaccine development and manufacturing, cancer biology R&D, CAR-T immunotherapy, cell and gene therapy, biomanufacturing and other areas, the company said.